The therapy of the inflammatory bowel diseases is quite complex. A partial compliance increases the relapse probability and the health expenditure. The aim of the study is to correctly study the adherence to the therapy in a single centre eliminating the bias of a different relationship of trust with different doctors.

The adherence to the therapy in inflammatory bowel disease: beyond the number of the tablets

Ribaldone, Davide Giuseppe;Vernero, Marta;Saracco, Giorgio Maria;Pellicano, Rinaldo;Finocchiaro, Fabio;Caviglia, Gian Paolo;
2017-01-01

Abstract

The therapy of the inflammatory bowel diseases is quite complex. A partial compliance increases the relapse probability and the health expenditure. The aim of the study is to correctly study the adherence to the therapy in a single centre eliminating the bias of a different relationship of trust with different doctors.
2017
53
2
141
146
Adherence; Crohn’s disease; mesalazine; therapy; ulcerative colitis
Ribaldone, Davide Giuseppe; Vernero, Marta; Saracco, Giorgio Maria; Pellicano, Rinaldo; Finocchiaro, Fabio; Caviglia, Gian Paolo; Astegiano, Marco
File in questo prodotto:
File Dimensione Formato  
Revised The Adherence.pdf

Accesso aperto

Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 195.39 kB
Formato Adobe PDF
195.39 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1654939
Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 15
  • ???jsp.display-item.citation.isi??? 14
social impact